MRKR – Marker Therapeutics Inc
Marker Therapeutics, Inc.MRKR
$0.9548Name : Marker Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $12,354,071.00
EPSttm : -1.35
Marker Therapeutics, Inc.
$0.9548
3.45%$0.0318Float Short %
2.55
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
0.11
EPS This/Next Y
0.49
Price
0.97
Target Price
6
Analyst Recom
1
Performance Q
-15.5
Relative Volume
0.2
Beta
1.38
Ticker: MRKR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | MRKR | 1.03 | N/A | N/A | 0 |
| 2025-10-21 | MRKR | 1.03 | N/A | N/A | 0 |
| 2025-10-22 | MRKR | 0.9804 | N/A | N/A | 0 |
| 2025-10-23 | MRKR | 0.99 | N/A | N/A | 0 |
| 2025-10-24 | MRKR | 1.04 | N/A | N/A | 0 |
| 2025-10-27 | MRKR | 1.02 | N/A | N/A | 0 |
| 2025-10-28 | MRKR | 1 | N/A | N/A | 0 |
| 2025-10-29 | MRKR | 0.9703 | N/A | N/A | 0 |
| 2025-10-30 | MRKR | 0.9844 | N/A | N/A | 0 |
| 2025-10-31 | MRKR | 0.9876 | N/A | N/A | 0 |
| 2025-11-03 | MRKR | 0.9501 | N/A | N/A | 0 |
| 2025-11-04 | MRKR | 0.8976 | N/A | N/A | 0 |
| 2025-11-05 | MRKR | 0.9175 | N/A | N/A | 0 |
| 2025-11-06 | MRKR | 0.8809 | N/A | N/A | 0 |
| 2025-11-07 | MRKR | 0.8646 | N/A | N/A | 0 |
| 2025-11-10 | MRKR | 0.955 | N/A | N/A | 0 |
| 2025-11-11 | MRKR | 0.9268 | N/A | N/A | 0 |
| 2025-11-12 | MRKR | 0.9435 | N/A | N/A | 0 |
| 2025-11-13 | MRKR | 0.892 | N/A | N/A | 0 |
| 2025-11-14 | MRKR | 0.9205 | N/A | N/A | 0 |
| 2025-11-17 | MRKR | 0.9712 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | MRKR | 1.03 | 19.2 | - | -1.08 |
| 2025-10-21 | MRKR | 1.03 | 19.2 | - | -1.08 |
| 2025-10-22 | MRKR | 0.99 | 19.2 | - | -1.08 |
| 2025-10-23 | MRKR | 0.99 | 19.2 | - | -1.08 |
| 2025-10-24 | MRKR | 1.03 | 19.2 | - | -1.08 |
| 2025-10-27 | MRKR | 1.03 | 19.2 | - | -1.08 |
| 2025-10-28 | MRKR | 1.01 | 19.2 | - | -1.08 |
| 2025-10-29 | MRKR | 0.98 | 19.2 | - | -1.08 |
| 2025-10-30 | MRKR | 0.99 | 19.2 | - | -1.08 |
| 2025-10-31 | MRKR | 0.99 | 19.2 | - | -1.08 |
| 2025-11-03 | MRKR | 0.95 | 19.2 | - | -1.08 |
| 2025-11-04 | MRKR | 0.91 | 19.2 | - | -1.08 |
| 2025-11-05 | MRKR | 0.92 | 19.2 | - | -1.08 |
| 2025-11-06 | MRKR | 0.88 | 19.2 | - | -1.08 |
| 2025-11-07 | MRKR | 0.86 | 19.2 | - | -1.08 |
| 2025-11-10 | MRKR | 0.97 | 19.2 | - | -1.08 |
| 2025-11-11 | MRKR | 0.93 | 19.2 | - | -1.08 |
| 2025-11-12 | MRKR | 0.94 | 19.2 | - | -1.08 |
| 2025-11-13 | MRKR | 0.89 | 19.2 | - | -1.08 |
| 2025-11-14 | MRKR | 0.95 | 19.2 | - | -1.08 |
| 2025-11-17 | MRKR | 0.97 | 19.2 | - | -1.08 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | MRKR | 0.00 | -7.47 | 6.86 |
| 2025-10-21 | MRKR | 0.00 | -7.47 | 6.86 |
| 2025-10-22 | MRKR | 0.00 | -7.47 | 6.86 |
| 2025-10-23 | MRKR | 0.00 | -7.47 | 6.86 |
| 2025-10-24 | MRKR | 0.00 | -7.47 | 6.86 |
| 2025-10-27 | MRKR | 0.00 | -7.73 | 3.11 |
| 2025-10-28 | MRKR | 0.00 | -7.73 | 3.11 |
| 2025-10-29 | MRKR | 0.00 | -7.73 | 3.11 |
| 2025-10-30 | MRKR | 0.00 | -7.73 | 3.11 |
| 2025-10-31 | MRKR | 0.00 | -7.73 | 3.11 |
| 2025-11-03 | MRKR | 0.00 | -7.47 | 3.11 |
| 2025-11-04 | MRKR | 0.00 | -7.47 | 3.11 |
| 2025-11-05 | MRKR | 0.00 | -7.47 | 3.11 |
| 2025-11-06 | MRKR | 0.00 | -7.47 | 3.11 |
| 2025-11-07 | MRKR | 0.00 | -7.47 | 3.11 |
| 2025-11-10 | MRKR | 0.00 | -7.38 | 2.90 |
| 2025-11-11 | MRKR | 0.00 | -7.38 | 2.90 |
| 2025-11-12 | MRKR | 0.00 | -7.38 | 2.55 |
| 2025-11-13 | MRKR | 0.00 | -7.38 | 2.55 |
| 2025-11-14 | MRKR | 0.00 | -7.38 | 2.55 |
| 2025-11-17 | MRKR | 0.00 | -0.46 | 2.55 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.21
Avg. EPS Est. Next Quarter
-0.21
Insider Transactions
Institutional Transactions
-0.46
Beta
1.38
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
18
Growth Score
38
Sentiment Score
26
Actual DrawDown %
97.4
Max Drawdown 5-Year %
-98
Target Price
6
P/E
Forward P/E
PEG
P/S
3.39
P/B
0.87
P/Free Cash Flow
EPS
-1.23
Average EPS Est. Cur. Y
-1.08
EPS Next Y. (Est.)
-0.59
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-304.54
Relative Volume
0.2
Return on Equity vs Sector %
-166.2
Return on Equity vs Industry %
-151.3
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Marker Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 5
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
stock quote shares MRKR – Marker Therapeutics Inc Stock Price stock today
news today MRKR – Marker Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MRKR – Marker Therapeutics Inc yahoo finance google finance
stock history MRKR – Marker Therapeutics Inc invest stock market
stock prices MRKR premarket after hours
ticker MRKR fair value insiders trading